Bird flu detected among chickens on a British farm
A case of bird flu has been confirmed in chickens at a farm in Hampshire although the Department for Environment, Food and Rural Affairs insist it is a 'low severity' case (Source: Telegraph Health)
Source: Telegraph Health - February 2, 2015 Category: Consumer Health News Tags: news hampshire flu pandemic bird tamiflu defra breaking britain Source Type: news

Totality of trials data confirm Tamiflu reduces length of symptoms, complications, and hospital admissions from influenza
The most thorough analysis of oseltamivir (marketed as Tamiflu) data to date, including all available published and unpublished randomised treatment trials of adults, suggests that the antiviral drug shortens the duration of flu symptoms by about a day, compared to placebo, in adults with laboratory-confirmed influenza. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 30, 2015 Category: Science Source Type: news

Tamiflu 'cuts hospital admissions for flu by 63% and shortens symptoms of the virus by a day' 
The drug Tamiflu gets flu victims back on their feet faster and reduces complications, claims new research. There had previously been lengthy debate over how effective the drug really was. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2015 Category: Consumer Health News Source Type: news

Tamiflu IS effective against influenza, major review finds
The most thorough study to date suggests that the controversial antiviral drug Tamiflu is effective (Source: Telegraph Health)
Source: Telegraph Health - January 30, 2015 Category: Consumer Health News Tags: flu cures how to beat flu symptoms tamiflu cures for flu have I got flu Source Type: news

Tamiflu DOES halt the spread of influenza, major review finds
The most thorough study to date suggests that the controversial antiviral drug Tamiflu is affective (Source: Telegraph Health)
Source: Telegraph Health - January 30, 2015 Category: Consumer Health News Tags: flu cures how to beat flu symptoms tamiflu cures for flu have I got flu Source Type: news

Tamiflu Cuts 1 Day Off Average Flu Bout, Study Finds
Researchers reviewed collected data on the influenza medication (Source: WebMD Health)
Source: WebMD Health - January 30, 2015 Category: Consumer Health News Source Type: news

Study supports Roche's disputed blockbuster flu drug Tamiflu
LONDON, Jan 30 (Reuters) - A major analysis of one of the world's most fiercely disputed medicines, Roche's Tamiflu, has found it cuts flu symptoms by a day and can help some patients avoid hospital treatment and complications. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Meta-Analysis: Oseltamivir Linked to Modest Improvements in Adults' Flu Symptoms (FREE)
By Kelly Young Edited by André Sofair, MD, MPH Oseltamivir (Tamiflu) is associated with faster resolution of flu symptoms in adults, in addition to lower odds of hospitalization, according to a Lancet meta-analysis. The study was conducted by an independent group that received an unrestricted grant … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 30, 2015 Category: Primary Care Source Type: news

Tamiflu Cuts 1 Day Off Average Flu Bout, Study Finds
Researchers reviewed collected data on the influenza medication Source: HealthDay Related MedlinePlus Pages: Flu, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 30, 2015 Category: Consumer Health News Source Type: news

Experts question industry-funded study showing benefits of Tamiflu
Meta-analysis shows it shortens symptom duration and curbs complication riskRelated items from OnMedicaDrug giant agrees to release all Tamiflu trial dataSpending watchdog criticises government over TamifluClinical confirmation of H7N9 virus resistance to TamifluTamiflu reduced risk of death in H1N1 influenza pandemicExperts call for Tamiflu use to be reviewed (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 30, 2015 Category: UK Health Source Type: news

Practices advised to prescribe Tamiflu despite concerns
Clinicians are being encouraged to prescribe Tamiflu to care and nursing home patients as a preventative measure, despite concerns about its effectiveness. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - January 29, 2015 Category: Nursing Source Type: news

Tamiflu helps, newest study in long-running debate says
Finding unlikely to end disagreement over drug’s value (Source: ScienceNOW)
Source: ScienceNOW - January 29, 2015 Category: Science Source Type: news

Study shows Tamiflu gets patients back on their feet faster, reduces flu complications
(University of Michigan) Earlier this month, the Centers for Disease Control and Prevention recommended the use of antiviral drugs to help treat influenza, in a year when the available vaccine is not a good match for the current strain. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 29, 2015 Category: Infectious Diseases Source Type: news

Diagnostics, Tamiflu help Roche full-year sales beat poll
ZURICH (Reuters) - Swiss drugmaker Roche expects sales and profits to grow at a similar pace to last year, after a strong performance by its diagnostics unit and flu drug Tamiflu helped full-year sales beat expectations. (Source: Reuters: Health)
Source: Reuters: Health - January 28, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Rx Pad: All About Oseltamivir
(MedPage Today) -- Everything there is to know about neuraminidase inhibitors. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 26, 2015 Category: Primary Care Source Type: news

GPs privately urged to prescribe Tamiflu despite concerns
WORKFORCE: NHS England is encouraging GPs to prescribe Tamiflu to care and nursing home patients as a preventative measure, despite concerns about its effectiveness. (Source: HSJ)
Source: HSJ - January 23, 2015 Category: UK Health Source Type: news

Pediatric Flu: One Size Does Not Fit All
(MedPage Today) -- Controversy continues over oseltamivir, but dont throw the baby out with the bathwater (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 21, 2015 Category: American Health Source Type: news

Why Transparency And Data Sharing In Clinical Trials Matters
We’re in the middle of a major flu epidemic, and the CDC has recommended treatment with an antiviral (e.g., Tamiflu or Relenza) for high-risk people. Yet there is considerable controversy over whether Tamiflu even works and, despite promises, Roche staunchly refused to release all their data for others to verify for years. The Cochrane Collaborative⁠ was finally able to review data and, in 2014, reported that Tamiflu did not reduce the number of hospitalizations, and they could not tell whether it reduced deaths. While it did reduce symptoms marginally (by less than one day), a large number of people who take it de...
Source: Forbes.com Healthcare News - January 15, 2015 Category: Pharmaceuticals Authors: Judy Stone Source Type: news

CDC urges wider use of antivirals to combat flu
In the midst of a serious flu outbreak, health officials are encouraging use of drugs like Tamiflu to shorten the illness (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 10, 2015 Category: Consumer Health News Source Type: news

Order Antivirals Before Influenza Is Lab-Confirmed, CDC SaysOrder Antivirals Before Influenza Is Lab-Confirmed, CDC Says
Underutilized antivirals such as oseltamivir can keep people out of the hospital and save lives, says the CDC, and in a bad flu season, they're needed more than ever. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2015 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

Flu season: The flu shot and what parents need to know now
The 2014-15 flu season is here, and it’s reached epidemic proportions. This season’s strain appears particularly nasty. About half of the United States is contending with high levels of flu activity, which means an onslaught of symptoms like fever, runny or stuff nose, cough and sore throat. Massachusetts has not been hit as hard as some other areas of the country. But the relative lull in flu activity might be the calm before the storm. The flu season will last for several more weeks, especially in areas that have not yet seen significant activity, according to the Centers for Disease Control and Prevention (C...
Source: Thrive, Children's Hospital Boston - January 6, 2015 Category: Pediatrics Authors: Lisa Fratt Source Type: news

FDA Approves Peramivir (Rapivab) for InfluenzaFDA Approves Peramivir (Rapivab) for Influenza
A neuraminidase inhibitor, peramivir is administered intravenously, unlike oseltamivir or zanamivir, giving clinicians another treatment option. FDA Approvals (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 23, 2014 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news

Questioning Medicine: Why Is Tamiflu Still Around?
(MedPage Today) -- Tamiflu doesn't help, so why are docs still prescribing it? (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - December 12, 2014 Category: Pediatrics Source Type: news

Oseltamivir Not Linked to Suicide Risk in Pediatric Patients
No significant link for oseltamivir exposure or flu diagnosis with suicide in case - crossover analysis (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 11, 2014 Category: Psychiatry Tags: Family Medicine, Infections, Nursing, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news

Baloxavir Superior to Placebo for Alleviating Flu Symptoms
Shorter median time to alleviation of symptoms versus placebo; similar alleviation time to oseltamivir (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Emergency Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Did Tamiflu reviewers have a bad case of the financial conflict bug?
We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital. By Tom Ulrich This winter, if your doctor suggests that you take Tamiflu, you might want to ask for a conflict of interest statement: a new study suggests that doctors who received payments from the makers of flu-fighting neuraminidase inhibitors – drugs like Tamiflu® and Relenza® – were more likely to view the drugs' prowes...
Source: Mass Device - October 17, 2014 Category: Medical Equipment Authors: MassDevice Tags: Vector Blog Source Type: news

Collaboration needed to wipe out rabies
Medics and vets must work together on preventionRelated items from OnMedicaCoronavirus ‘not yet reached pandemic potential’Tamiflu reduced risk of death in H1N1 influenza pandemicUN describes Ebola as ‘threat to peace and security’Global effort to fight Ebola threat - stepped upMore investment needed to prevent new pandemics (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 29, 2014 Category: UK Health Source Type: news

Oseltamivir and Influenza -- The Rush to JudgmentOseltamivir and Influenza -- The Rush to Judgment
A meta-analysis of oseltamivir therapy in healthy adults and children showed minimal clinical effectiveness but did not address the issue of oseltamivir use in severely ill or hospitalized patients. Society for Healthcare Epidemiology of America (SHEA) (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - May 23, 2014 Category: Infectious Diseases Tags: Infectious Diseases Viewpoint Source Type: news

Tamiflu: drugs given for swine flu 'were waste of £500m'
Drug Tamiflu does nothing to halt the spread of influenza and Government wasted nearly £500?million stockpiling it over swine flu pandemic, study finds (Source: The Telegraph : Swine Flu A H1N1)
Source: The Telegraph : Swine Flu A H1N1 - May 13, 2014 Category: Infectious Diseases Tags: influenza drugs pandemic tamiflu swine flu Source Type: news

Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered
(University of Helsinki) Researchers at the Institute for Molecular Medicine Finland FIMM, University of Helsinki, with their collaborators have shown that first Tamiflu resistant pandemic influenza pH1N1 viruses have emerged in Finland. Furthermore, they have identified a novel antiviral agent MK2206 and shown that the pH1N1 viruses are not able to develop resistance against it. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 24, 2014 Category: Infectious Diseases Source Type: news

Tamiflu & Relenza: How effective are they?
Experts call on government and health policy decision makers to review guidance on use of Tamiflu in light of the most recent evidence. Tamiflu (the antiviral drug oseltamivir) shortens symptoms of influenza by half a day, but there is no good evidence to support claims that it reduces admissions to hospital or complications of influenza. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 11, 2014 Category: Science Source Type: news

Tamiflu and Relenza: How effective are they?
Experts call on government and health policy decision makers to review guidance on use of Tamiflu in light of the most recent evidence. Tamiflu (the antiviral drug oseltamivir) shortens symptoms of influenza by half a day, but there is no good evidence to support claims that it reduces admissions to hospital or complications of influenza. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 11, 2014 Category: Science Source Type: news

Altmetric tracks the buzz around scholarly articles: You can make a difference
Altmetric tracks the buzz around scholarly articles - see an example: http://bit.ly/1lF9KtR You can make a difference. See how my blog contributed to one of highest ever scores in this journal for this article (ranked #7 of 972): Children with severe asthma have 32 times higher risk for developing COPD http://buff.ly/1oIJ3FHHere is the blog post: Allergy Notes: What are the top 3 asthma articles for March 2014? Vote here http://bit.ly/1hjZ6JuThe article will be included in the next edition of What Is New In Small Airways Researchhttp://www.worldallergy.org/small_airways_group/reviews/The beautiful flower of Inter...
Source: Clinical Cases and Images - April 11, 2014 Category: Journals (General) Tags: Social Media Twitter Source Type: news

Study Says Gov't Wasted Billions on Flu Drugs that Won't Stop Pandemics
Cochrane Collaboration, an independent network of research scientists, has said that governments who stockpile Roche's flu medicine Tamiflu and GlaxoSmithKline's drug Relenza are wasting billions of dollars on a drugs with doubtful effectiveness. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 10, 2014 Category: Pharmaceuticals Source Type: news

Tamiflu: Government 'must listen' to findings
Dr Fiona Godlee, editor in chief of the British Medical Journal, says the system for drug regulation is "clearly flawed", while Dr Daniel Thurley, UK medical director of Roche, says he disagrees with the findings of a report questioning the efficacy of Tamiflu (Source: The Telegraph : Health Advice)
Source: The Telegraph : Health Advice - April 10, 2014 Category: Consumer Health News Source Type: news

Cochrane review questions benefit of Tamiflu
Ministers should review the use of a widely used anti-flu medication, researchers have said after their review questioned the efficacy of the drug oseltamivir (Tamiflu). (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - April 10, 2014 Category: Nursing Source Type: news

Effectiveness of Tamiflu and Relenza questioned
ConclusionThis major review is particularly significant for its use of unpublished, previously confidential data from both the drug manufacturers and regulators, to verify the information in published trials. As the researchers point out, much of the trial data is unreliable for various reasons, which makes it difficult to draw firm conclusions.While it appears that these drugs have a modest benefit, there is no solid evidence that either drug can protect people from the more serious complications of influenza. Paracetamol or ibuprofen would seem to be a far more cost-effective method of relieving the symptoms of influenza...
Source: NHS News Feed - April 10, 2014 Category: Consumer Health News Tags: Medication Swine flu Source Type: news

Review calls for Tamiflu rethink
Ministers should review the use of a widely used anti-flu medication, scientists have said after new research questioned the efficacy of the drug. (Source: HSJ)
Source: HSJ - April 10, 2014 Category: UK Health Source Type: news

Billions wasted on unproven flu drug, report claims
Researchers raise doubts over effectiveness of stockpiled medicine Tamiflu (Source: The Irish Times - Health)
Source: The Irish Times - Health - April 10, 2014 Category: Consumer Health News Source Type: news

Governments wasting billions on flu drug, report claims
Researchers raise doubts over effectiveness of stockpiled medicine Tamiflu (Source: The Irish Times - Health)
Source: The Irish Times - Health - April 10, 2014 Category: Consumer Health News Source Type: news

What the Tamiflu saga tells us about drug trials and big pharma
We now know the government's Tamiflu stockpile wouldn't have done us much good in the event of a flu epidemic. But the secrecy surrounding clinical trials means there's a lot we don't know about other medicines we takeToday we found out that Tamiflu doesn't work so well after all. Roche, the drug company behind it, withheld vital information on its clinical trials for half a decade, but the Cochrane Collaboration, a global not-for-profit organisation of 14,000 academics, finally obtained all the information. Putting the evidence together, it has found that Tamiflu has little or no impact on complications of flu infection, ...
Source: Guardian Unlimited Science - April 10, 2014 Category: Science Authors: Ben Goldacre Tags: Pharmaceuticals industry Science Medical research Flu Health Controversies Business Source Type: news

Tamiflu, Relenza Data Show Little Clinical Benefit Against Flu (FREE)
By Joe Elia The neuraminidase inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza) have only marginal benefits in the treatment and prevention of influenza, a series of BMJ articles concludes.Investigators reviewed documents submitted to regulatory agencies concerning both drugs.Tamiflu data showed … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 10, 2014 Category: Primary Care Source Type: news

Experts call for Tamiflu use to be reviewed
Large analysis says Tamiflu has small benefit and increased risksRelated items from OnMedicaQuestions remain about effectiveness of Tamiflu, experts warnClinical confirmation of H7N9 virus resistance to TamifluDrug giant agrees to release all Tamiflu trial dataSpending watchdog criticises government over TamifluTamiflu reduced risk of death in H1N1 influenza pandemic (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 10, 2014 Category: UK Health Source Type: news

Tamiflu - Oral Anti-Viral Treatment Agent
Tamiflu or oseltamivir is a prescription drug used for prophylaxis and treatment of flu caused by influenza virus types A (H1N1) and B. (Source: Drug Development Technology)
Source: Drug Development Technology - April 10, 2014 Category: Pharmaceuticals Source Type: news

Armed With New Data, Researchers Again Challenge Effectiveness of Antiflu Drug
New study questions strategy of stockpiling oseltamivir in case of flu pandemics (Source: ScienceNOW)
Source: ScienceNOW - April 9, 2014 Category: Science Source Type: news

Tamiflu-resistant influenza related to mutations in genome
It doesn't take long for the flu virus to outsmart Tamiflu. Scientists have developed a tool that reveals the mutations that make the virus resistant, and they have identified new mutations that may render ineffective one of the few treatments currently available on the market. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 31, 2014 Category: Science Source Type: news

Tamiflu-resistant influenza: Parsing the genome for the culprits
(Ecole Polytechnique Fédérale de Lausanne) It doesn't take long for the flu virus to outsmart Tamiflu. EPFL scientists have developed a tool that reveals the mutations that make the virus resistant, and they have identified new mutations that may render ineffective one of the few treatments currently available on the market. Their research is published in PLOS Genetics. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 31, 2014 Category: Biology Source Type: news

Clonal Expansion of H274Y pH1N1 Tamiflu Resistance In PA
The commentary discusses the clonal expansion of H274Y pH1N1 Tamiflu resistance in Pennsylvania in 2014. (03/28/14 23:45) (Source: Recombinomics)
Source: Recombinomics - March 29, 2014 Category: Infectious Diseases Source Type: news

Well: Antiviral Drugs Cut Flu Deaths, Study Finds
Tamiflu and its siblings reduced the mortality rate in hospitalized patients by as much as 50 percent, researchers say.     (Source: NYT)
Source: NYT - March 28, 2014 Category: American Health Authors: By NICHOLAS BAKALAR Tags: Influenza Body medicine and health Featured Tamiflu (Drug) Source Type: news